About Sequrna

About SEQURNA

SEQURNA AB is a pioneering biotech startup spun out from Karolinska Institutet, specializing in synthetic thermostable RNase inhibitors for RNA-focused workflows. Our innovative technology simplifies RNA-sequencing and in situ sequencing processes, making them more accessible, cost-effective, and sustainable. Based in Stockholm and partnered with Nasdaq-Nordic-listed Genovis AB, SEQURNA is at the forefront of enabling next-generation RNA research and diagnostics worldwide.

SEQURNA management team

Board Member & Co-founder. CEO

Björn Reinius, PhD

Björn Reinius (PhD) is a chemist and Associate Professor at the Department of Medical Biochemistry and Biophysics at the Karolinska Institute. He and his academic laboratory is known for major discoveries in X-chromosome regulation and early groundbreaking work on RNA-extraction-free molecular assays for diagnostics of Covid-19, which has been applied in millions of clinical tests internationally. Björn is the CEO and a Co-founder of SEQURNA.

Board Member and Chairman. CEO Genovis

Fredrik Olsson, Civ Eng

Fredrik Olsson has broad experience of production processes from the biotechnology and food industry where a large part of his work involves establishing processes and quality systems for various industry-specific standards as well as a general system. Fredrik is the Chairman of the Board and CEO of Genovis.
Genovis is a biotech company listed on Nasdaq First North Growth Market specializing in the development of innovative enzyme-based tools in life science research and biopharmaceutical applications. Since summer 2024,Genovis owns 25% of shares in SEQURNA.

Board Member & Co-founder. R&D Molecular Assays

Joyce Noble, PhD

Joyce Carol Noble (PhD) is a molecular biologist with special expertise in RNA regulation and detection techniques. Joyce is the Lead Research & Development Specialist and is a Board Member and Co-founder of SEQURNA.

Co-founder. R&D Bioinformatics

Antonio Lentini, PhD

Antonio Lentini (PhD) is a bioinformatician with a wide expertise in sequencing-based methodologies and single-cell techniques. He is the Lead Computational Research & Development Specialist, and Co-founder of SEQURNA.

Board Member. Senior Scientific Advisor

Rickard Sandberg, PhD

Rickard Sandberg is Professor at the Department of Cell & Molecular Biology at the Karolinska Institute and a pioneer in the field of single-cell genomics. He and his academic laboratory is known for multiple breakthroughs in transcriptomics, including the development of widely used single-cell RNA-seq methods, such as Smart-seq, Smart-seq2, Smart-seq3, Small-seq, NASC-seq. Rickard is the Senior Scientific Advisor at SEQURNA.

R&D Molecular Assays

Michael Hagemann-Jensen, PhD

Michael Hagemann-Jensen (PhD) is a methods specialist in RNA biology and biotechnology. He is acclaimed for spearheading the development of multiple refined single-cell RNA-seq protocols, such as Smart-seq3, Smart-seq3xpress, and Small-seq. Michael is a Research & Development Specialist at SEQURNA

Marketing Manager

Sushmita Choudhury

Sushmita Sruti Choudhury is a trained pharmacist and a passionate advocate for merging science with business with years of experience in working in product development and marketing strategy. Simultaneously with her work at SEQURNA, she is pursuing an MSc in Bioentrepreneurship at the Karolinska Institute.